| Date Filed | Type | Description |
| 08/02/2023 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 275,000 options to buy
@ $3.54, valued at
$973.5k
|
|
| 08/02/2023 |
3
| Dananberg Jamie (Chief Medical Officer) has filed a Form 3 on Annexon, Inc. |
| 04/03/2023 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 420 shares
@ $1.7, valued at
$714 |
|
| 03/15/2023 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,005 shares
@ $4, valued at
$4k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,016 shares
@ $2.85, valued at
$2.9k
|
|
| 11/21/2022 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 65,000 options to buy
@ $2.38, valued at
$154.7k
|
|
| 09/15/2022 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 10,923 shares
@ $0.48, valued at
$5.2k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Paid exercise price by delivering 4,188 shares
@ $1.14, valued at
$4.8k
|
|
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 45,833 shares
@ $0
Granted 183,333 options to buy
@ $1.06, valued at
$194.3k
|
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2020 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 240,000 shares
@ $0 |
|
| 06/24/2020 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Paid exercise price by delivering 2,483 shares
@ $9.67, valued at
$24k
|
|
| 04/01/2020 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 24,255 shares
@ $0
Granted 98,490 options to buy
@ $5.95, valued at
$586k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2018 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Converted 74,048 shares
@ $0
Converted 1,630 shares
@ $0
Converted 74,048 preferred shares
@ $0
Converted 1,630 preferred shares
@ $0 |
|
| 05/04/2018 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 30,508 options to buy
@ $17, valued at
$518.6k
|
|
| 05/02/2018 |
3
| Dananberg Jamie (Chief Medical Officer) has filed a Form 3 on Unity Biotechnology, Inc. |